Similar articles for PMID: 17909269

Year	Number of Results
1983	1
1985	1
1988	1
1995	4
1996	3
1997	1
1998	1
1999	2
2000	3
2001	4
2002	3
2003	5
2004	13
2005	13
2006	13
2007	12
2008	21
2009	17
2010	12
2011	12
2012	11
2013	13
2014	10
2015	12
2016	11
2017	4
2018	7
2019	6
2020	3
2021	4
2022	4
2023	1
2024	0

1

Oligonucleotide microarray analysis of estrogen receptor alpha-positive postmenopausal breast carcinomas: identification of HRPAP20 and TIMELESS as outstanding candidate markers to predict the response to tamoxifen.

Tozlu-Kara S, Roux V, Andrieu C, Vendrell J, Vacher S, Lazar V, Spyratos F, Tubiana-Hulin M, Cohen P, Dessen P, Lidereau R, Bièche I. Tozlu-Kara S, et al. J Mol Endocrinol. 2007 Oct;39(4):305-18. doi: 10.1677/JME-07-0001. J Mol Endocrinol. 2007. PMID: 17909269

2

A candidate molecular signature associated with tamoxifen failure in primary breast cancer.

Vendrell JA, Robertson KE, Ravel P, Bray SE, Bajard A, Purdie CA, Nguyen C, Hadad SM, Bieche I, Chabaud S, Bachelot T, Thompson AM, Cohen PA. Vendrell JA, et al. Breast Cancer Res. 2008;10(5):R88. doi: 10.1186/bcr2158. Epub 2008 Oct 17. Breast Cancer Res. 2008. PMID: 18928543 Free PMC article.

3

Expression analysis of estrogen receptor alpha coregulators in breast carcinoma: evidence that NCOR1 expression is predictive of the response to tamoxifen.

Girault I, Lerebours F, Amarir S, Tozlu S, Tubiana-Hulin M, Lidereau R, Bièche I. Girault I, et al. Clin Cancer Res. 2003 Apr;9(4):1259-66. Clin Cancer Res. 2003. PMID: 12684393

4

The CGA gene as new predictor of the response to endocrine therapy in ER alpha-positive postmenopausal breast cancer patients.

Bièche I, Parfait B, Noguès C, Andrieu C, Vidaud D, Spyratos F, Lidereau R, Vidaud M. Bièche I, et al. Oncogene. 2001 Oct 18;20(47):6955-9. doi: 10.1038/sj.onc.1204739. Oncogene. 2001. PMID: 11687975 Clinical Trial.

5

High tumoral levels of Kiss1 and G-protein-coupled receptor 54 expression are correlated with poor prognosis of estrogen receptor-positive breast tumors.

Marot D, Bieche I, Aumas C, Esselin S, Bouquet C, Vacher S, Lazennec G, Perricaudet M, Kuttenn F, Lidereau R, de Roux N. Marot D, et al. Endocr Relat Cancer. 2007 Sep;14(3):691-702. doi: 10.1677/ERC-07-0012. Endocr Relat Cancer. 2007. PMID: 17914099

6

Co-expression of estrogen receptor alpha and Apolipoprotein D in node positive operable breast cancer--possible relevance for survival and effects of adjuvant tamoxifen in postmenopausal patients.

Søiland H, Skaland I, Varhaug JE, Kørner H, Janssen EA, Gudlaugsson E, Baak JP, Søreide JA. Søiland H, et al. Acta Oncol. 2009;48(4):514-21. doi: 10.1080/02841860802620613. Acta Oncol. 2009. PMID: 19107621

7

Comparison of gene expression profiles predicting progression in breast cancer patients treated with tamoxifen.

Kok M, Linn SC, Van Laar RK, Jansen MP, van den Berg TM, Delahaye LJ, Glas AM, Peterse JL, Hauptmann M, Foekens JA, Klijn JG, Wessels LF, Van't Veer LJ, Berns EM. Kok M, et al. Breast Cancer Res Treat. 2009 Jan;113(2):275-83. doi: 10.1007/s10549-008-9939-y. Epub 2008 Mar 4. Breast Cancer Res Treat. 2009. PMID: 18311582

8

Estrogen receptor beta (ER beta) level but not its ER beta cx variant helps to predict tamoxifen resistance in breast cancer.

Esslimani-Sahla M, Simony-Lafontaine J, Kramar A, Lavaill R, Mollevi C, Warner M, Gustafsson JA, Rochefort H. Esslimani-Sahla M, et al. Clin Cancer Res. 2004 Sep 1;10(17):5769-76. doi: 10.1158/1078-0432.CCR-04-0389. Clin Cancer Res. 2004. PMID: 15355905

9

Outcome prediction for estrogen receptor-positive breast cancer based on postneoadjuvant endocrine therapy tumor characteristics.

Ellis MJ, Tao Y, Luo J, A'Hern R, Evans DB, Bhatnagar AS, Chaudri Ross HA, von Kameke A, Miller WR, Smith I, Eiermann W, Dowsett M. Ellis MJ, et al. J Natl Cancer Inst. 2008 Oct 1;100(19):1380-8. doi: 10.1093/jnci/djn309. Epub 2008 Sep 23. J Natl Cancer Inst. 2008. PMID: 18812550 Free PMC article.

10

Prognostic factors of early distant recurrence in hormone receptor-positive, postmenopausal breast cancer patients receiving adjuvant tamoxifen therapy: results of a retrospective analysis.

Debled M, MacGrogan G, Brouste V, Mathoulin-Pelissier S, Durand M, Mauriac L. Debled M, et al. Cancer. 2007 Jun 1;109(11):2197-204. doi: 10.1002/cncr.22667. Cancer. 2007. PMID: 17450590 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

204 results

Results by year